124 related articles for article (PubMed ID: 325130)
21. Mixed leukocyte culture reactivity of lymph node cells regional to transitional cell carcinoma of the bladder.
Herr HW; Bean MA; Whitmore WF
Natl Cancer Inst Monogr; 1978 Dec; (49):177-81. PubMed ID: 155221
[TBL] [Abstract][Full Text] [Related]
22. In vitro augmentation of cytotoxicity against tumor cell lines by mumps virus.
Morales A; Ottenhof P; Elliott M
Invest Urol; 1980 Jan; 17(4):284-7. PubMed ID: 6927978
[TBL] [Abstract][Full Text] [Related]
23. In vitro generation of cytotoxic lymphocytes by tumor extracts of transitional cell carcinoma.
Morales A
Natl Cancer Inst Monogr; 1978 Dec; (49):173-4. PubMed ID: 748769
[TBL] [Abstract][Full Text] [Related]
24. Classification of the bladder cancer patient based on in vitro measurements of the immune response.
Lange PH; Hakala TR; Fraley EE
Cancer Res; 1977 Aug; 37(8 Pt 2):2885-90. PubMed ID: 326395
[TBL] [Abstract][Full Text] [Related]
25. Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: 51Cr-release assay.
Troye M; Perlmann P; Larsson A; Blomgren H; Johansson B
Int J Cancer; 1977 Aug; 20(2):188-98. PubMed ID: 892930
[No Abstract] [Full Text] [Related]
26. Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?
O'Toole C; Perlmann P; Wigzell H; Unsgaard B; Zetterlund CG
Lancet; 1973 May; 1(7812):1085-8. PubMed ID: 4123535
[No Abstract] [Full Text] [Related]
27. Transitional cell carcinoma: circulating tumor antigen correlated with presence/absence of tumor (leukocyte migration assay).
Bowen JG
Natl Cancer Inst Monogr; 1978 Dec; (49):245-7. PubMed ID: 748778
[TBL] [Abstract][Full Text] [Related]
28. Characterization of cell-mediated cytolytic mechanisms against human transitional cell carcinoma line, 253J.
Catalona WJ; Ratliff TL; McCool RE
Immunology; 1980 Jan; 39(1):119-25. PubMed ID: 7380462
[TBL] [Abstract][Full Text] [Related]
29. [Immunohistochemical characterization of lymphocytes and histiocytes in bladder cancers in terms of local immune responses].
Hanai S; Shimosato Y; Watanabe S; Sato Y; Kishi K; Kakizoe T; Matsumoto K
Gan No Rinsho; 1985 Jun; 31(7):839-46. PubMed ID: 2411967
[TBL] [Abstract][Full Text] [Related]
30. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
31. In vitro cytotoxicity studies in bladder and renal cell cancer.
Elhilali MM; Nayak SK
Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
[TBL] [Abstract][Full Text] [Related]
32. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
Bkhatta AD; Makhlin NV
Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
[No Abstract] [Full Text] [Related]
33. Immunological status of patients with bladder cancers (transitional cell tumours).
Frantz P; Khoury S; Kuss R
Prog Clin Biol Res; 1984; 162A():201-8. PubMed ID: 6385023
[No Abstract] [Full Text] [Related]
34. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
[TBL] [Abstract][Full Text] [Related]
35. Tretinoin or retinol enhancement of lymphokine-activated killer cell proliferation and cytotoxicity against human bladder cancer cells in vitro.
Wang ZP; Zheng RL; Chen YR; Liu GD
Zhongguo Yao Li Xue Bao; 1997 Nov; 18(6):522-4. PubMed ID: 10322910
[TBL] [Abstract][Full Text] [Related]
36. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
Hakala TR
Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
[TBL] [Abstract][Full Text] [Related]
37. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
38. Skin tests with soluble tumor membrane antigens in patients with transitional cell cancers.
Hollinshead AC
Natl Cancer Inst Monogr; 1978 Dec; (49):255-6. PubMed ID: 748779
[TBL] [Abstract][Full Text] [Related]
39. Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma.
Perlmann P; O'Toole C; Unsgaard B
Natl Cancer Inst Monogr; 1972 Dec; 35():223-9. PubMed ID: 4540587
[No Abstract] [Full Text] [Related]
40. Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop.
Bean MA; Bloom BR; Herberman RB; Old LJ; Oettgen HF; Klein G; Terry WD
Cancer Res; 1975 Oct; 35(10):2902-13. PubMed ID: 1157057
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
